Bamco Inc. NY Takes Position in Tenet Healthcare Corporation $THC

Bamco Inc. NY purchased a new position in Tenet Healthcare Corporation (NYSE:THC) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,500 shares of the company’s stock, valued at approximately $711,000.

Other large investors also recently added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of Tenet Healthcare during the second quarter worth approximately $206,981,000. Boston Partners grew its stake in Tenet Healthcare by 95.0% in the second quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after purchasing an additional 1,104,500 shares in the last quarter. AQR Capital Management LLC increased its holdings in Tenet Healthcare by 62.3% during the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after purchasing an additional 720,160 shares during the period. Alliancebernstein L.P. raised its position in Tenet Healthcare by 375.7% during the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after purchasing an additional 624,125 shares in the last quarter. Finally, Holocene Advisors LP purchased a new stake in shares of Tenet Healthcare in the 2nd quarter worth $102,855,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Down 3.5%

NYSE:THC opened at $219.58 on Tuesday. The company’s 50-day simple moving average is $213.71 and its 200-day simple moving average is $204.56. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $247.21. The stock has a market capitalization of $19.09 billion, a P/E ratio of 14.18, a P/E/G ratio of 1.10 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. Tenet Healthcare’s revenue was up 8.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at $6,983,853.13. This trade represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 46,517 shares of company stock worth $10,943,111. Insiders own 0.81% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Wells Fargo & Company restated an “overweight” rating and set a $265.00 price target on shares of Tenet Healthcare in a research note on Monday, February 16th. KeyCorp increased their target price on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Thursday, February 12th. Truist Financial boosted their price target on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday, March 1st. Finally, Royal Bank Of Canada lifted their price objective on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $250.56.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.